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ABSTRACT 
Objective: To develop a accurate, precise and specific RP-HPLC method for simultaneous estimation of Tapentadol HCl (TAP), Aceclofenac (ACE) 
and Paracetamol (PCM) in its laboratory synthetic mixture. 
Methods: The optimized method uses C8 Thermo quest, hypersil division, 250*4.60 mm; 5 μ column, mobile phase consisting of phosphate buffer 
(pH 3) and acetonitrile in the ratio of 40:60, flow rate 0.8 ml/min. The detection wavelength was set at 217 nm. 
Results: The developed method resulted Paracetamol, Tapentadol HCl and Aceclofenac in eluting at 4.008 min 4.595 min and 6.073 min 
respectively. Linearity was observed over the concentration range of 52-130 µg/ml for PCM, 16-40 µg/ml for ACE and 12-30 µg/ml for TAP. The 
percentage recovery was found to be in the range of 98-102% at three different levels of a standard addition. The precision (intra-day, inter-day) of 
the method was within the limit (RSD<2%).  
Conclusion: The proposed method was found to be accurate, precise, reproducible and specific and it can be used for qualitative and quantitative 
determination of Tapentadol HCl, Aceclofenac and Paracetamol in their combined dosage form in the pharmaceutical industry. 
Keywords: Tapentadol HCl, Aceclofenac, Paracetamol, RP-HPLC, Isocratic, Simultaneous estimation. 
 
INTRODUCTION 
Paracetamol is N-acetyl-p-aminophenol (fig. 1 a) having analgesic, 
antipyretic with weak antiinflammatory action [1, 2]. Tapentadol 
hydrochloride is 3-[(1R, 2R)-3-(dimethyl amino)-1-ethyl-2 
methylpropyl] phenol monohydrochloride (fig. 1 b). Agonists of the 
μ-opioid receptor are being used conventionally for the treatment of 
moderate to severe pain. Tapentadol hydrochloride (TAP) is 
centrally-acting oral analgesic [3, 4]. Aceclofenac is 2-[(2, 6-
dichlorophenyl) amino] phenylacetoxyacectic acid (fig. 1 c) having 
potent analgesic and anti-inflammatory properties [5]. 
 
 
Fig. 1: Stucture of (a) Paracetamol, (b) Tapentadol 
hydrochloride (c) Aceclofenac 
 
Survey of literature revealed that several methods have been 
reported for the individual analysis of Tapentadol hydrochloride [6-
12], Aceclofenac [13-14] and Paracetamol [15-16] by UV 
Spectrophotometric and RP-HPLC methods. UV Spectrophotometric 
method and RP-HPLC methods are available in the literature for 
simultaneous determination of Aceclofenac and Paracetamol [17-
20], Paracetamol and Tapentadol [21, 22]. However, as per our 
knowledge, no RP-HPLC Method has been reported for simultaneous 
estimation of Tapentadol hydrochloride, Aceclofenac and 
Paracetamol till date. The aim of the present work was to develop an 
easy, economic, accurate and specific HPLC method for simultaneous 
estimation of Tapentadol hydrochloride, Aceclofenac and 
Paracetamol in combined pharmaceutical formulation. The 
developed method was validated as per ICH guide line. [23]. 
MATERIALS AND METHODS 
Chemicals and reagents 
Pure drug sample of TAP was gifted by Ami Life Science Pvt. Ltd., 
Mumbai and reference drug samples of ACE and PCM were gifted by 
Theopharma Pvt. Ltd, Ahmedabad. The gift samples were used as 
standard without any purification. Methanol and acetonitrile (HPLC 
grade) were procured from Spectrochem Pvt Ltd. Mumbai. Double 
distilled water (Purified HPLC grade water) was obtained by 
filtering double distilled water through nylon filter paper 0.2 μm 
pore size and 47 mm diameter (Pall Life Sciences, Mumbai, India). 
Potassium dihydrogen orthophosphate purified was procured from 
S D Fine Chem. Ltd, Mumbai. Triethanolamine (HPLC grade) was 
procured from Spectrochem Pvt. Ltd., Mumbai. Ortho phosphoric 
acid HPLC grade was procured from Loba Chemie Pvt. Ltd., Mumbai. 
Instrumentation 
The HPLC was performed on a Shimadzu (Shimadzu Corporation, 
Kyoto, Japan) chromatography system equipped with Shimadzu LC-
20AT pump and SPD-20AV UV detector. Samples were injected 
through a Rheodyne 7725 injector valve with fixed loop at 20μl. The 
column C8 Thermo quest, hypersil division (250*4.60 mm, 5μm 
particle size) was used. Data acquisition and integration were 
performed using Spin-chrome software. 
Preparation of synthetic laboratory mixture 
The Combined Dosage Formulation of TAP, ACE and PCM is of Orbit 
Life Sciences Pvt. Ltd., Mumbai[24] which was not available in the local 
market, so a synthetic laboratory mixture (laboratory sample) was 
prepared using the excipients mentioned in the literature[25-27]. 
Laboratory sample contained Tapentadol HCl (75 mg), Aceclofenac 
(100 mg), and Paracetamol (325 mg) with excipients microcrystalline 
cellulose, Lactose monohydrate, Povidone, Magnesium stearate and 
this laboratory sample was used for further analysis. 
Preparation of mobile phase 
Accurately weighed 0.27 g of potassium di hydrogen orthophosphate 
was transferred into a 100 ml volumetric flask and about 90 ml of 
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water was added. The mixture was sonicated and finally diluted with 
water up to 100 ml. Then 0.1% v/v Triethylamine was added and pH 
3 was adjusted with ortho-phosphoric acid. This buffer was filtered 
through 0.2 μm filter paper and mixed with acetonitrile in the ratio 
of 40:60 into a mobile phase bottle. The prepared mixture was 
sonicated for 5 min and then used as the mobile phase. 
Preparation of stock solution 
Stock solutions of PCM (1000 µg/ml), ACE (1000 µg/ml) and TAP 
(1000 µg/ml) were prepared in acetonitrile solvent. Then primary 
working solutions of all three drugs PCM, ACE, TAP (200µg/ml) 
were prepared in the mobile phase. From primary working solutions 
aliquots ranging from 2.6 ml to 6.5 ml for PCM, 0.8 ml to 2 ml for 
ACE and 0.6 ml to 1.5 ml for TAP were taken in 10 ml volumetric 
flasks respectively, sufficient amount of mobile phase was added and 
sonicated, then the volume was made up to 10 ml with mobile phase 
that gave final concentrations 52, 65, 78, 91, 104, 117, 130 µg/ml of 
PCM, 16, 20, 24, 28, 32, 36, 40 µg/ml of ACE and 12, 15, 18, 21, 24, 
27, 30 µg/ml of TAP as standard solution of mixtures respectively.  
Preparation of synthetic laboratory mixture solution 
Powder equivalent to 325 mg of PCM, 100 mg of ACE and 75 mg of 
TAP from a synthetic laboratory mixture was transferred to 100 ml 
volumetric flask. Sufficient amount of acetonitrile was added and 
sonicat, the volume was made up to 100 ml with acetonitrile. The 
Solution was filtered through Whatman filter paper (No. 42) to get a 
stock sample solution. An aliquot of 10 ml was pipetted out of a 
stock sample solution and diluted up to 50 ml with the mobile phase. 
An aliquot of 1 ml was taken from the above solution and diluted up 
to 10 ml with the mobile phase to obtain 65µg/ml PCM, 20µg/ml 
ACE and 15µg/ml TAP. This solution was injected in to 
chromatographic system to obtain chromatogram which was 
quantified for PCM, ACE and TAP. 
Selection of detection wavelength 
The Analytical wavelength for the analysis of PCM, ACE and TAP was 
selected by scanning standard solutions in the range of 200-400 nm. 
At the selected wavelength 217 nm, three drugs are having 
appreciable absorbance. Overlay UV spectra of PCM, ACE and TAP 
are shown in fig. 2. 
 
 
Fig. 2: Selection of wavelength 
 
RESULTS AND DISCUSSION 
HPLC method development 
HPLC method was optimized for efficient separation and simultaneous 
quantification of PCM, ACE and TAP. The pKa value reported for PCM, 
ACE and TAP are 9.38, 4.7 and 9.34 respectively, whereas, log p values 
for the three drugs are 0.46, 2.17 and 2.87 respectively. Because of 
this, the chromatographic separation of the three drugs on the basis of 
polarity or pH of the mobile phase was a challenge. A number of 
solvents in different ratio over a wide range of pH were tried, but 
either peak shape was broad or resolution was not good. Repeated 
trials to obtain good, sharp peak with efficient resolution between two 
peaks of Paracetamol and Tapentadol done on C18, phenomenex 
column in isocratic HPLC did not give satisfactory results. The peak 
shapes were good in some trials but Retention time was not in the 
acceptable range while gradient elution was tried on C18 column. The 
run time was high in gradient trial on the C 18 phenomenex column. 
So, further trials were taken on C8, thermo quest column in isocratic 
HPLC. The mobile phase consisting of phosphate buffer (pH 3) and 
acetonitrile in the ratio of 40:60 and C8 Thermo quest, hypersil 
division, 250*4.60 mm 5 μm columns, flow rate 0.8 ml/min and 
detection wavelength 217 nm gave the satisfactory results in terms of 
retention time, resolution, symmetry and sensitivity. 
 
 
Fig. 3: Chromatogram of ternary mixture PCM, TAP and ACE 
 
Method validation 
As per ICH guideline, objective of validation of an analytical 
procedure is to demonstrate that it is suitable for its intended 
purpose. The developed method was validated as per ICH guideline. 
Linearity 
The linearity of an analytical procedure is its ability (within a given 
range) to obtain test results which are directly proportional to the 
concentration of analyte in the sample. Minimum six concentrations 
were analyzed for linearity study. A linear response was obtained in 
the concentration range of 52-130 µg/ml for PCM, 16-40 µg/ml for 
ACE and 12-30 µg/ml for TAP. The linearity graphs were plotted 
using the concentration verses peak area for PCM, ACE and TAP in 
fig: 4, fig: 5 and fig: 6 respectively. 
 
 
Fig. 4: Calibration curve for PCM in ternary mixture 
 
 
Fig. 5: Calibration curve for ACE in ternary mixture 
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Fig. 6: Calibration curve for TAP in ternary mixture 
 
Accuracy 
The accuracy of the method was determined by recovery 
experiments using the standard addition method. The 50%, 100% 
and 150% of standard solution were added to previously analyzed 
solution of a laboratory sample. For the three drugs, the recovery 
studies were performed in triplicate and percentage recovery were 
calculated. The results are shown in table 1. 
Precision 
The precision of an analytical procedure expresses the closeness of 
agreement between a series of measurements obtained from 
multiple sampling of the same homogeneous sample under the 
prescribed conditions. The precision of the method was determined 
as Intra-day and inter-day. The experiments were repeated three 
times in a day for intra-day and on three different days for inter-day 
precision and results were reported as percentage RSD. The results 
are shown in table 2. From the data obtained, the developed RP-
HPLC method was found to be precise. 
Limit of detection (LOD) and limit of quantification (LOQ) 
The limit of detection (LOD) is defined as the lowest concentration 
of an analyte that an analytical process can reliably differentiate 
from background levels. The limit of quantification (LOQ) is defined 
as the lowest concentration of the standard curve that can be 
measured with acceptable accuracy, precision and variability. The 
LOD and LOQ of Tapentadol HCL, Aceclofenac and Paracetamol were 
determined by using the signal to noise ratio. The Limit of detection 
was 3.12µg/ml for PCM, 1.24µg/ml for ACE and 0.91µg/ml for TAP 
at a signal to noise ratio of 3.1. The limit of quantification was 
determined as 9.45µg/ml for PCM, 3.76µg/ml for ACE and 
2.75µg/ml for TAP at a signal to noise ratio of 10:1. 
Robustness 
The robustness of an analytical procedure is a measure of its 
capacity to remain unaffected by small, but deliberate variations in 
method parameters and provides an indication of its reliability 
during normal usage. Robustness of the method was studied by 
deliberate variation in method parameter like changes in flow rate, 
mobile phase ratio and pH of the mobile phase. It was concluded that 
method is enough robust and will provide accurate results in normal 
quality control labs even if there is some sort of experimental error 
by human or system. None of the modifications caused a significant 
change in the resolution between the drugs, peak area % RSD. The 
results were shown in table 3. 
 
Table 1: Recovery results for TAP, ACE and PCM 
% spiked Amount Added (µg/ml) Amount Found* (µg/ml) % Recovery (mean±SD) 
 TAP ACE PCM TAP ACE PCM TAP ACE PCM 
50 % 3 4 13 2.98 4.04 12.85 99.5±0.93 101.08±0.8 99.13±1.38 
100 % 6 8 26 6.05 8.01 25.53 100.84±0.49 100.71±1.44 99.34±1.29 
150 % 9 12 39 9.02 12.14 39.42 100.27±0.98 100.66±0.9 99.73±1.89 
Avg. 100.2±0.8 100.82±1.05 99.4±1.52 
 *Average of three determination 
 
Table 2: Validation parameters of HPLC method of Tapentadol HCL, Aceclofenac, Paracetamol 
Parameter Tapentadol HCl Aceclofenac Paracetamol 
Detection wavelength 217 nm 217 nm 217 nm 
Linearity and range 12-30 μg/ml 16-40 μg/ml 52-130 μg/ml 
Slope 25.766 59.428 26.471 
Intercept -3.9615 -121.55 -72.17 
Correlation coefficient 0.9988 0.9978 0.9992 
Precision (% RSD)  
Intraday precision 1.185 0.510 0.533 
Interday precision 1.491 0.967 1.166 
  
Table 3: Robustness Results for PCM, TAP and ACE 
Factor Area (mV·S) 
pH PCM TAP ACE 
2.9 1722.80 362.73 1184.47 
3 1715.64 371.97 1224.97 
3.1 1718.84 375.75 1187.48 
%RSD 0.20 1.80 1.88 
Mobile phase ratio 
62: 38 1712.87 374.43 1204.09 
60:40 1715.64 371.97 1224.97 
58: 42 1707.07 375.79 1191.55 
%RSD 0.25 0.51 1.39 
Flow rate 
0.7 1747.82 379.01 1244.25 
0.8 1715.64 371.97 1224.97 
0.9 1691.99 365.65 1198.22 
%RSD 1.63 1.79 1.89 
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Table 4: System suitability parameters validated RP-HPLC method 
Parameter PCM TAP ACE 
Retention time (min)±SD 4.008±0.0016 4.595±0.0019 6.073±0.0068 
Theoretical plate per meter±SD 5902.7±216.80 5981.4±132.18 5836±69.98 
Tailing factor±SD 1.4388±0.030 1.4115±0.026 0.770±0.013 
Resolution±SD - 2.533±0.024 5.917±0.078 
 
Table 5: Assay of synthetic laboratory mixture sample 
Synthetic Laboratory Mixture 
Labelled Claim: PCM: ACE: TAP (325 mg: 100 mg: 75 mg) 
% ASSAY PCM* ACE* TAP* 
(mean*±SD) 101.29±0.38 101.30±0.31 100.74±1.32 
 * Average of three determination 
 
System suitability parameters 
System suitability parameters were studied to verify the optimum 
conditions. The System suitability test was performed as per USP 
guidelines on the chromatograms. Different parameters were 
evaluated such as resolution, tailing factor, theoretical plates. The 
results were shown in table 4. 
Assay of synthetic laboratory mixture 
The three drug combined dosage formulation is developed by Orbit 
Life Sciences Pvt Ltd, Mumbai and is shown on their website but not 
available in local pharmacies. A simulated laboratory mixture was 
used as the sample and analyzed using the proposed method. For the 
analysis, three replicates batches were assayed. The mean peak area 
of each drug was calculated and the drug content in the synthetic 
laboratory mixture was quantified. The results found were 
comparable with the corresponding true values and are shown in 
table 5. 
CONCLUSION 
The proposed RP-HPLC method is found to be simple, specific, 
accurate, precise, robust, rapid and economical. This method gives 
good resolution between all the three compounds with a short 
analysis time. The proposed RP-HPLC method can be useful for 
routine analysis of PCM, ACE and TAP in the combined dosage form. 
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